Marina Tuyishime

Journal Article Vaccines (Basel) · February 24, 2025 Background: The RV144 trial in Thailand is the only HIV-1 vaccine efficacy trial to date to demonstrate any efficacy. Genetic signatures suggested that antibodies targeting the variable loop 2 (V2) of the HIV-1 envelope played an important protective role. ... Full text Link to item Cite

AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaques.

Journal Article Nat Med · October 2023 The main barrier to HIV cure is a persistent reservoir of latently infected CD4+ T cells harboring replication-competent provirus that fuels rebound viremia upon antiretroviral therapy (ART) interruption. A leading approach to target this reservoir involve ... Full text Link to item Cite

Functional consequences of allotypic polymorphisms in human immunoglobulin G subclasses.

Journal Article Immunogenetics · February 2023 Heritable polymorphisms within the human IgG locus, collectively termed allotypes, have often been linked by statistical associations, but rarely mechanistically, to a wide range of disease states. One potential explanation for these associations is that I ... Full text Cite

View All Publications

Education, Training & Certifications

Drexel University · 2016 Ph.D.

Richard Stockton College · 2009 B.S.

Marina Tuyishime

Current Appointments & Affiliations

Recent Publications

Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge.

AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaques.

Functional consequences of allotypic polymorphisms in human immunoglobulin G subclasses.

Recent Grants

Targeting CD180 to induce anti-KSHV response in nonhuman primates

Quantitative Methods for HIV/AIDS Research

SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens

Education, Training & Certifications